Results 51 to 60 of about 112 (79)

Dynamics of T Cell-Mediated Immune Signaling Network During Pathogenesis of Chronic Obstructive Pulmonary Disease. [PDF]

Yonsei Med J
Lee CM, Kim AS, Kim M, Jeong JW, Jo S, Hwang N, Fang S.   +6 more
europepmc   +1 more source

N-acetylcysteine in the Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. [PDF]

Cureus, 2019
Ansari SF, Memon M, Brohi N, Tahir A.
europepmc   +1 more source

Inactivation of FOXA2 by Respiratory Bacterial Pathogens and Dysregulation of Pulmonary Mucus Homeostasis. [PDF]

Front Immunol, 2020
Choi W, Choe S, Lau GW.
europepmc   +1 more source

[Mucoregulators: specificity of carbocysteine].

Srpski arhiv za celokupno lekarstvo, 1990
openaire   +1 more source

Physiology and pathophysiology of mucus and mucolytic use in critically ill patients. [PDF]

Crit Care
Roe T, Talbot T, Terrington I, Johal J, Kemp I, Saeed K, Webb E, Cusack R, Grocott MPW, Dushianthan A.   +9 more
europepmc   +1 more source

Addressing treatable traits in bronchiectasis through non-pharmacological therapies: a narrative review. [PDF]

J Thorac Dis
Lee AL, Spinou A, Basavaraj A.
europepmc   +1 more source

What will Happen in the World of COPD 2030? [PDF]

Turk Thorac J, 2019
Russell REK, Bafadhel M.
europepmc   +1 more source

Ambroxol hydrochloride spray (Luo Runchang®) in the treatment of acute respiratory infectious diseases: a prospective, multicenter, open label, randomized controlled study. [PDF]

Front Pediatr
Cheng L, Liu M, Wang R, Cao S, Li R, Su B, Wei H, Yang H, Hou L, Geng C, Han Y, Yang T.   +11 more
europepmc   +1 more source

Integrated traditional Chinese medicine and Western medicine strategies for the treatment of bronchiectasis: a comprehensive review. [PDF]

Chin Med
Ou-Yang Y, Zeng LX, Xing YY, Zhou H, Wu QB.   +4 more
europepmc   +1 more source

To: Out-of-bed extubation: a feasible study. [PDF]

Rev Bras Ter Intensiva, 2015
Blanco JB, Esquinas AM.
europepmc   +1 more source